Meeting
2024 ASCO Annual Meeting
A blind validation of a deep-learning solution providing HER2, ER, and PR results from H&E-stained breast cancer specimens.
Authors
Elizabeth Walsh
University of Leeds, Leeds, United Kingdom
Elizabeth Walsh , Salim Arslan , Andre Geraldes , Andrew Hanby , Rebecca Millican-Slater , Nicholas Bennett , Bejal Mistry , Julian Schmidt , Steffen Wolf , Cher Bass , Foivos Ntelemis , Naren Kumar , Pahini Pandya , Nicolas M. Orsi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 562)
DOI
10.1200/JCO.2024.42.16_suppl.562
Abstract #
562
Poster Bd #
154
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Variations in measured ER, PR, and HER2 status in synchronous and asynchronous paired breast cancer (BC) tumors.
First Author: Clayton Yates
Poster
2014 Breast Cancer Symposium
Breast cancer subtypes in Chinese Americans: A study from the Mount Sinai Health System.
First Author: Camila Masias
Poster
2013 ASCO Annual Meeting
Identification of the activated form of the progesterone receptor (PR) in breast cancer (BC).
First Author: Jacques Bosq
Poster
2012 Breast Cancer Symposium
Ki-67, p53, and clinical outcomes of patients with triple-negative breast cancer.
First Author: Yasuyuki Nishiyama